Table 1 Patients baseline characteristics.
Clinicopathologic features | Clinicopathologic features | ||||
|---|---|---|---|---|---|
Age, years | median (range) | 58(26–83) | Albumin, g/L | median (range) | 40.1 (25.2–51.3) |
<60/≥60 | 122/99 | >35 vs ≤35 | 182/39 | ||
Gender | male/female | 178/43 | ALT, U/L | median (range) | 31 (7–1210) |
Etiology | HBV/HCV/others | 181/1/39 | ≤40/>40 | 143/78 | |
Child score | A/B | 193/28 | AST, U/L | median (range) | 34 (13–743) |
Cirrhosis | absent/present | 182/39 | ≤40/>40 | 139/82 | |
Tumor number | 1/2/3 | 150/49/22 | ALK, U/L | median (range) | 102 (48–746) |
Tumor size, cm | median (range) | 4(1–10) | ≤110/>110 | 125/96 | |
≤3/3–5/>5 | 78/88/55 | GGT, U/L | median (range) | 69.25 (8.7–1395.3) | |
Tumor location | non-risk/risk areas* | 129/92 | ≤50/>50 | 83/138 | |
AFP, ng/ml | median (range) | 23.4(1–50000) | Tbil, μmol/L | median (range) | 15.9 (2.4–97.9) |
≤20/20–400/>400 | 105/62/54 | ≤25/>25 | 174/47 | ||
PT, sec | median (range) | 12(9.1–20.2) | Creatine, μmol/L | median (range) | 63 (22.3–144.1) |
≤14/>14 | 199/22 | ≤110 vs >110 | 217/4 | ||
INR | median (range) | 1.02(0.82–1.67) | CLIP | 0/1/2/3 | 104/86/25/6 |
<1.3/≥1.3 | 214/7 | BCLC | 0/A/B | 16/117/88 | |
Platelets count, 109/L | median (range) | 107 (42–432) | |||
>100/≤100 | 117/104 | ||||
